A randomized trial (MA.17R) of extending adjuvant letrozole for 5 years after completing an initial 5 years of aromatase inhibitor therapy alone or preceded by tamoxifen in postmenopausal women with early-stage breast cancer. Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Goss, Paul E
  • Ingle, James N
  • Pritchard, Kathleen I
  • Robert, Nicholas J
  • Muss, Hyman
  • Gralow, Julie
  • Gelmon, Karen A
  • Whelan, Timothy
  • Strasser-Weippl, Kathrin
  • Rubin, Sheldon
  • Sturtz, Keren
  • Wolff, Antonio C
  • Winer, Eric P
  • Hudis, Clifford A
  • Stopeck, Alison
  • Beck, J Thaddeus
  • Kaur, Judith Salmon
  • Whelan, Kate
  • Tu, Dongsheng
  • Parulekar, Wendy R

publication date

  • June 20, 2016